M&A

Is AstraZeneca a Better Suitor for Relypsa Than Sanofi?
Bidness, ETC
Mon, 12/28/15 - 10:03 am
AstraZeneca
Relypsa
Sanofi
Merck
M&A
Could These Hot 2015 Biotech IPOs Be 2016 Buyout Targets?
24/7 Wall St
Mon, 12/28/15 - 10:01 am
M&A
biotech
IPOs
Seres Therapeutics
Collegium Pharmaceutical
Spark Therapeutics
The top biopharma trends for 2016
Fierce Biotech
Sun, 12/27/15 - 10:32 am
IPOs
M&A
venture capital
drug pricing
globalization
Shire's Baxalta buyout looks more and more likely as year winds down
Fierce Biotech
Thu, 12/24/15 - 10:26 am
Shire
Baxalta
M&A
AstraZeneca May Acquire Relypsa for $46/Share; Stock Surges
Bidness, ETC
Thu, 12/24/15 - 10:24 am
AstraZeneca
Relypsa
M&A
Relypsa Gets More Attractive For Merck, Sanofi
Bidness, ETC
Wed, 12/23/15 - 09:26 pm
Relypsa
Merck
Sanofi
M&A
Baxalta fielding buyout offers, but may land with Shire after all
BioPharma Dive
Wed, 12/23/15 - 11:10 am
Baxalta
Shire
M&A
Big Biotech Still ‘On the Hunt’ For Pipeline Fillers: Mizhuho
Barron's
Wed, 12/23/15 - 11:05 am
biotech
M&A
Did AbbVie Blow $21 Billion Buying Pharmacyclics?
Motley Fool
Tue, 12/22/15 - 10:02 pm
AbbVie
Pharmacyclics
M&A
The Right Drug For Big Pharma: Precision M&A
Seeking Alpha
Tue, 12/22/15 - 10:55 am
M&A
AstraZeneca
GSK
JNJ
Novartis
Sanofi
Pfizer Inc Mega-Merger to Pit Bayer and Reckitt Against Each Other
Bidness, ETC
Tue, 12/22/15 - 10:48 am
Pfizer
M&A
Bayer
Reckitt Benckiser
consumer health
Amgen buys another cancer-fighting virus project in a $10.5M deal
Fierce Biotech
Tue, 12/22/15 - 10:45 am
Amgen
Catherex
oncovirus
M&A
AstraZeneca's Acerta deal could put the hurt on AbbVie's Imbruvica
Fierce Pharma Marketing
Tue, 12/22/15 - 10:40 am
AstraZeneca
Acerta
AbbVie
M&A
Imbruvica
Ready to step up M&A, Bayer could target big game like Pfizer's OTC unit, Zoetis
Fierce Pharma
Mon, 12/21/15 - 02:59 pm
M&A
Bayer
Pfizer
Zoetis
OTC
animal health
Can Shire, Baxalta Merge Within Weeks On Improved Bid?
Bidness, ETC
Mon, 12/21/15 - 11:03 am
Shire
Baxalta
M&A
FTC Signals Aggressive Stance On Healthcare Mergers
Forbes
Sun, 12/20/15 - 04:37 pm
FTC
M&A
After shareholder revolt, Astellas says it needs more time for proposed buyout of Ocata
Bizjournals.com
Fri, 12/18/15 - 09:01 am
Astellas
Ocata Therapeutics
M&A
shareholders
Why AstraZeneca Acquired Majority Stake in Acerta?
Bidness, ETC
Thu, 12/17/15 - 09:44 am
AstraZeneca
Acerta Pharma
M&A
acalabrutinib
Why Shire-Baxalta Deal May Not Materialize After All
Bidness, ETC
Thu, 12/17/15 - 09:31 am
Shire
Baxalta
M&A
Five predictions for medtech in 2016
Mass Device
Thu, 12/17/15 - 09:30 am
devices
data
diagnostics
M&A

Pages